“Just in Time,” which for a year starred Jonathan Groff, is the first new musical from last season to make money for investors.
Category: Theater (Broadway)
-
Bobby Darin Musical Reaches a Rare Broadway Milestone: Profit
The New York Times – Business: -
When Mark Consuelos Wants to Escape New York, He Goes Here
The New York Times – Business:“The midcentury architecture is fascinating. It’s also a place where I’m outside almost every waking hour of the day.”
-
Justice Dept. Resolves Broadway Touring Company Investigation
The New York Times – Business:Broadway Across America will not be prosecuted after acknowledging it signed a noncompete agreement with another presenter, the agency said.
-
Theater Tickets Are Cheaper in London Than New York. What Gives?
The New York Times – Business:For half the price of a great seat at a Broadway show, you can see “Paddington” in the West End (if you can find a ticket) and snack on a marmalade sandwich.
-
Fed Up With High Costs, American Theater Takes a Trip to London
The New York Times – Business:Skyrocketing budgets and falling profitability have driven a new form of offshoring, with U.S. producers staging shows across the Atlantic.
-
How Lesley Manville Is Leaving ‘Oedipus’ Audiences Spellbound
Personal history emerges by painful degrees in “Oedipus,” whose language and story, the actress Lesley Manville says, “wreck me every time.”
-
Roger Allers Dies at 76; Helped Put ‘Lion King’ on Screens and Onstage
A Disney fan who once “flew” off his couch as a 4-year-old Peter Pan, he was a co-director of the animated film and a co-writer of the Broadway musical, both of them megahits.
-
‘The Outsiders’ Musical Recoups on Broadway
“The Outsiders” is the first new musical to open since 2022 to become profitable.
-
‘Hell’s Kitchen’ Will End Broadway Run and Open Overseas
Though the show will close in New York next month, a North American tour will continue, and productions in Australia, Germany and South Korea are planned.
-
Adrien Brody and Tessa Thompson to Star in ‘Fear of 13’ on Broadway
The play, about a man who spends decades on death row before being exonerated by DNA evidence, will have a 16-week run this spring.